NCT00205504View on ClinicalTrials.gov

Oral Contraceptives in the Metabolic Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Metabolic Syndrome XInsulin ResistanceObesityCardiovascular Diseases
Interventions
DRUG

Ortho Tri Cyclen

Ortho Tri Cyclen, one tablet daily, for 6 cycles

Trial Locations (1)

23298

Virginia Commonwealth University General Clinical Research Center, Richmond

All Listed Sponsors
lead

Virginia Commonwealth University

OTHER

NCT00205504 - Oral Contraceptives in the Metabolic Syndrome | Biotech Hunter | Biotech Hunter